Amber Salter
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Amber Salter has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Florian Patrick Thomas
Hackensack Meridian School of Medicine
2 shared publications - Louise H. Flick
College for Public Health and Social Justice, Saint Louis University, 3545 Lafayette Avenue, St. Louis, MO, 63104, USA
2 shared publications - Marilyn Rantz
Sinclair School of Nursing, University of Missouri, Columbia, MO, United States
2 shared publications - Marjorie Skubic
Electrical Engineering & Computer Science, University of Missouri, Columbia, MO
2 shared publications - Pamela Newland
Goldfarb School of Nursing at Barnes Jewish College, St. Louis, MO, USA
2 shared publications Alyssa Kimutis
1 shared publication
Latest Publications
- 1 October 2017
- Published by Elsevier in Disability and Health Journal
- Vol. 10 (4) , 587-591
The link between smoking status and co-morbid conditions in individuals with multiple sclerosis (MS)
- 1 October 2017
- Published by Elsevier in Disability and Health Journal
- Vol. 10 (4) , 587-591
The link between smoking status and co-morbid conditions in individuals with multiple sclerosis (MS)
- 1 August 2017
- Published by Wolters Kluwer Health in Journal of Neuroscience Nursing
- Vol. 49 (4) , 241-246
Continuous In-Home Symptom and Mobility Measures for Individuals With Multiple Sclerosis: A Case Presentation
Gait impairment represents one of the most common and disabling symptoms of multiple sclerosis (MS). To identify which temporal or spatial parameters of gait could be used as outcome measures in interventional studies of individuals with MS with different levels of disability, we evaluated characteristics of these parameters in a case study of 3 participants with MS, using 1 case as an exemplar and the other participants as validation. A case study of an exemplar participant was conducted with a 67-year-old woman with secondary progressive MS served as exemplar, with 2 other participants (52 and 55 years old) as validation. The primary outcome measures we used were stride time, stride length, gait velocity, and daily symptoms. Stride length and velocity of gait decreased with increasing pain and fatigue. The step time was significantly longer later in the day, whereas the step length remained the same. Stride length and velocity are associated with the level of fatigue and pain, as well as the time of day. These characteristics and parameters of gait need to be considered in future studies of gait in MS, with particular attention to temporality of occurrence in persons with MS.
- 1 August 2017
- Published by Wolters Kluwer Health in Journal of Neuroscience Nursing
- Vol. 49 (4) , 241-246
Continuous In-Home Symptom and Mobility Measures for Individuals With Multiple Sclerosis: A Case Presentation
Gait impairment represents one of the most common and disabling symptoms of multiple sclerosis (MS). To identify which temporal or spatial parameters of gait could be used as outcome measures in interventional studies of individuals with MS with different levels of disability, we evaluated characteristics of these parameters in a case study of 3 participants with MS, using 1 case as an exemplar and the other participants as validation. A case study of an exemplar participant was conducted with a 67-year-old woman with secondary progressive MS served as exemplar, with 2 other participants (52 and 55 years old) as validation. The primary outcome measures we used were stride time, stride length, gait velocity, and daily symptoms. Stride length and velocity of gait decreased with increasing pain and fatigue. The step time was significantly longer later in the day, whereas the step length remained the same. Stride length and velocity are associated with the level of fatigue and pain, as well as the time of day. These characteristics and parameters of gait need to be considered in future studies of gait in MS, with particular attention to temporality of occurrence in persons with MS.
- 1 October 2016
- Published by Wolters Kluwer Health in Neurology Clinical Practice
- Vol. 6 (5) , 397-408
Examining the joint effect of disability, health behaviors, and comorbidity on mortality in MS
Background: In multiple sclerosis (MS), comorbidities have been associated with disability progression and an increased risk of mortality. We investigated the association between comorbidities and mortality in MS after accounting for disability and health behaviors. Methods: We followed North American Research Committee on Multiple Sclerosis (NARCOMS) Registry participants who completed the Fall 2006 survey on comorbidities until death (reported or matched in the National Death Index) or date of last follow-up in 2014. We used proportional hazards regression to investigate the association between comorbidities and mortality, controlling for demographic, clinical, health behavior, and disability factors. Results: Of 9,496 participants meeting the inclusion criteria, 502 (5.3%) were deceased. Most participants reported having ≤3 comorbid conditions (70.9% survivors, 76.9% decedents). In individual regression models, vascular, visual, and mental comorbidities were associated with increased mortality risk after adjustment for factors associated with survival. When combined into a single model, vascular (hazard ratio 1.269; 1.041–1.547), visual (1.490; 1.199–1.852), and mental comorbidities (excluding anxiety, 1.239; 1.024–1.499) remained independently associated with an increased risk of mortality. Conclusions: Presence of comorbidities was independently associated with an increased risk of mortality as compared to absence of comorbidities after adjusting for factors associated with survival. Specifically, vascular, visual, and mental comorbidities increased the risk of mortality. This highlights the need for clinicians to attend to these comorbidities, which can be modified by treatments or other interventions, and potentially reduce the risk of mortality in persons with MS who have these conditions.
- 1 October 2016
- Published by Wolters Kluwer Health in Neurology Clinical Practice
- Vol. 6 (5) , 397-408
Examining the joint effect of disability, health behaviors, and comorbidity on mortality in MS
Background: In multiple sclerosis (MS), comorbidities have been associated with disability progression and an increased risk of mortality. We investigated the association between comorbidities and mortality in MS after accounting for disability and health behaviors. Methods: We followed North American Research Committee on Multiple Sclerosis (NARCOMS) Registry participants who completed the Fall 2006 survey on comorbidities until death (reported or matched in the National Death Index) or date of last follow-up in 2014. We used proportional hazards regression to investigate the association between comorbidities and mortality, controlling for demographic, clinical, health behavior, and disability factors. Results: Of 9,496 participants meeting the inclusion criteria, 502 (5.3%) were deceased. Most participants reported having ≤3 comorbid conditions (70.9% survivors, 76.9% decedents). In individual regression models, vascular, visual, and mental comorbidities were associated with increased mortality risk after adjustment for factors associated with survival. When combined into a single model, vascular (hazard ratio 1.269; 1.041–1.547), visual (1.490; 1.199–1.852), and mental comorbidities (excluding anxiety, 1.239; 1.024–1.499) remained independently associated with an increased risk of mortality. Conclusions: Presence of comorbidities was independently associated with an increased risk of mortality as compared to absence of comorbidities after adjusting for factors associated with survival. Specifically, vascular, visual, and mental comorbidities increased the risk of mortality. This highlights the need for clinicians to attend to these comorbidities, which can be modified by treatments or other interventions, and potentially reduce the risk of mortality in persons with MS who have these conditions.
- 1 September 2016
- Published by Elsevier in Gait & Posture
- Vol. 49, 277-282
Exploring the feasibility and acceptability of sensor monitoring of gait and falls in the homes of persons with multiple sclerosis
- 1 September 2016
- Published by Elsevier in Gait & Posture
- Vol. 49, 277-282
Exploring the feasibility and acceptability of sensor monitoring of gait and falls in the homes of persons with multiple sclerosis